Fecal transplants could protect newborns from antibiotics that killed ‘good’ gut bacteria, study finds
Fecal transplants could potentially protect newborns who received antibiotics that killed “good” gut bacteria
Fecal transplants could potentially protect newborns who received antibiotics that killed “good” gut bacteria
If successful, Dr. Moonah’s work would be the first to deliver a drug treatment using an amoeba or another protozoan.
Neutrophils, a type of white blood cell, fight infection, clear away cell debris, and heal injured tissue. In diseases with chronic or excessive inflammation (e.g., arthritis, sepsis), however, they can also cause tissue damage. Scientists at the University of Illinois, Chicago, recently identified two distinct subtypes of neutrophils, and designed a way to preserve the neutrophils’ favorable effects while their anti-inflammatory properties fight disease.
A therapy involving the continuous release of nitric oxide could help with obesity and related conditions like Type 2 diabetes.
Scientists at the Salk Institute for Biological Studies in San Diego discovered that the use of reprogramming molecules can improve cell growth and speed liver regeneration.
A recent study may lead to new gut microbiome-based therapies to normalize function of the pancreas and GI tract hormones in obese diabetes patients.
New research suggests there is a way to optimize treatments for inflammatory bowel disease, or IBD.
Inspired by ancient technology, engineers have designed a new device to assess problems in gut motility.
A new study shows that narrow-spectrum antibiotics are effective in selectively eliminating the harmful strain Clostridium difficile (C. diff) while sparing nearby and harmless bacteria.
Researchers found that glial cells coordinate immune responses of the gut following pathogen invasion or insult to the tissues.